Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials

Abstract Objective To compare the outcomes associated with the use of lasmiditan, rimegepant, ubrogepant, and zavegepant for the acute management of migraine headaches. Methods We searched four electronic databases from database inception to August 31, 2023, to identify randomized controlled trials...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Xinxin Deng, Liying Zhou, Cui Liang, Xue Shang, Xu Hui, Wendi Liu, Shanshan Liang, Yongsheng Wang, Meng Xu, Kangle Guo, Kehu Yang, Xiuxia Li
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2024-02-01
Цуврал:	The Journal of Headache and Pain
Нөхцлүүд:	Acute treatments Migraine Lasmiditan CGRP Network meta-analyses Efficacy
Онлайн хандалт:	https://doi.org/10.1186/s10194-024-01723-4
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!